Arcturus Therapeutics Holdings Inc.
Ticker: 1768224
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.06-88.0% | 17.15-39.4% | 28.30-3.7% | 29.38-29.5% | 41.67-16.4% | 49.86+31.2% | 38.01-15.8% | 45.14 |
| Total Income | 2.06-88.0% | 17.15-39.4% | 28.30-3.7% | 29.38-29.5% | 41.67-16.4% | 49.86+31.2% | 38.01-15.8% | 45.14 |
| EXPENSES | ||||||||
| Expenditure | 30.99-7.9% | 33.66-15.7% | 39.92-13.6% | 46.21-11.8% | 52.41-26.2% | 70.99+3.8% | 68.42+6.2% | 64.45 |
| Tax | — | — | 0.00 | 0.00+100.0% | -0.22-46.7% | -0.15-140.5% | 0.37-58.4% | 0.89 |
| PROFIT | ||||||||
| PBT | — | -13.45-46.5% | -9.18+34.8% | -14.08-97.8% | -7.12+59.0% | -17.37+34.3% | -26.45-72.5% | -15.33 |
| Net Profit | -26.96-100.4% | -13.45-46.5% | -9.18+34.8% | -14.08-104.1% | -6.90+59.9% | -17.22+35.8% | -26.82-65.4% | -16.22 |
| KEY METRICS | ||||||||
| OPM % | -100.00%-3.72pp | -96.27%-55.23pp | -41.04%+16.22pp | -57.27%-31.50pp | -25.77%+16.61pp | -42.37%+37.63pp | -80.01%-37.22pp | -42.79% |
| NPM % | -100.00%-21.59pp | -78.41%-45.97pp | -32.44%+15.47pp | -47.91%-31.34pp | -16.57%+17.96pp | -34.53%+36.02pp | -70.55%-34.61pp | -35.94% |
| EPS | -0.95-93.9% | -0.49-44.1% | -0.34+34.6% | -0.52-100.0% | -0.26+59.4% | -0.64+36.0% | -1.00-63.9% | -0.61 |
Corporate Events
Board MeetingARCT
20265Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve n…
SEC Filing ↗ Board MeetingARCT
20261May
Board Meeting
CFO Appointment and Q1 2026 Financial Results Effective May…
SEC Filing ↗